|
|
Neil J. Freedman, Robert J. Lefkowitz
J Clin Invest. 2004;
113(10):1379
doi:10.1172/JCI21748
Abstract |
Full text
| PDF
A
ntibodies specific for the β1-adrenergic receptor are found in patients with chronic heart failure of various etiologies. From work presented in this issue of the JCI, we can now infer that these antibodies actually contribute to the pathogenesis of chronic heart failure. This commentary discusses mechanisms by which these antibodies may engender cardiomyopathy.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(9)
| Title and authors |
Publication |
Year |
Cardiac 1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study
N. Deubner, D. Berliner, A. Schlipp, G. Gelbrich, A. L. P. Caforio, S. B. Felix, M. Fu, H. Katus, C. E. Angermann, M. J. Lohse, G. Ertl, S. Stork, R. Jahns
|
European Journal of Heart Failure
|
2010 |
Update on Peripartum Cardiomyopathy
Meredith O. Cruz, Joan Briller, Judith U. Hibbard
|
Obstetrics and Gynecology Clinics of North America
|
2010 |
Real-time optical recording of β1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol
Francesca Rochais, Jean-Pierre Vilardaga, Viacheslav O. Nikolaev, Moritz Bünemann, Martin J. Lohse, Stefan Engelhardt
|
J. Clin. Invest.
|
2007 |
Autoantibody against β1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment
G. B. Miao, J. C. Liu, M. B. Liu, J. L. Wu, G. Zhang, J. Chang, L. Zhang
|
European Journal of Clinical Investigation
|
2006 |
Selective blockade of nicotinic acetylcholine receptors by pimobendan, a drug for the treatment of heart failure: reduction of catecholamine secretion and synthesis in adrenal medullary cells
Yumiko Toyohira, Tatsuhiko Kubo, Miyabi Watanabe, Yasuhito Uezono, Susumu Ueno, Koji Shinkai, Masato Tsutsui, Futoshi Izumi, Nobuyuki Yanagihara
|
Naunyn-Schmied Arch Pharmacol
|
2005 |
Effects of Immunoglobulin G from Patients with Dilated Cardiomyopathy on Rat Cardiomyocytes
Torsten Christ, Esther Adolph, Stefan Schindelhauer, Erich Wettwer, Dobromir Dobrev, Gerd Wallukat, Ursula Ravens
|
Basic Clin Pharmacol Toxicol
|
2005 |
Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
T. Douglas Bradley, Alexander G. Logan, R. John Kimoff, Frédéric Sériès, Debra Morrison, Kathleen Ferguson, Israel Belenkie, Michael Pfeifer, John Fleetham, Patrick Hanly, Mark Smilovitch, George Tomlinson, John S. Floras
|
N Engl J Med
|
2005 |
Receptor function reserve: a new parameter for disease detection
H. William Strauss
|
Eur J Nucl Med Mol Imaging
|
2004 |
Molecular genetics and genomics of heart failure
Choong-Chin Liew, Victor J. Dzau
|
Nat Rev Genet
|
2004 |
|
